ADVANCED/METASTATIC SOLID TUMORS
Clinical trials for ADVANCED/METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets tough cancers: early trial seeks safer, smarter treatment
Disease control Recruiting nowThis early-stage study tests a new drug called PF-08046876 in people with advanced cancers of the bladder, lung, head and neck, esophagus, or pancreas. The drug is designed to stick to cancer cells and kill them directly. The main goals are to check safety, find the best dose, an…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 16, 2026 22:30 UTC
-
New Dual-Action antibody enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called HLX37 in people with advanced or metastatic solid tumors (cancers that have spread). The drug is a bispecific antibody that targets two proteins (PD-L1 and VEGF) involved in tumor growth. The main goals are to check the drug's safety, find the r…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: EARLY_PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 16, 2026 22:29 UTC
-
New hope for advanced cancers: first human trial of DB-1317 begins
Disease control Recruiting nowThis early-stage study tests a new drug called DB-1317 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. About 233 adults will take part in two phases: first to check …
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated May 16, 2026 22:27 UTC
-
New drug ATG 022 tested in patients with hard-to-treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called ATG 022 in 156 adults with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to find the safest dose and to see if the drug can shrink tumors or slow their growth. Participants wil…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Antengene Biologics Limited • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug SYS6043 shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study is testing a new drug called SYS6043 in people with advanced or metastatic solid tumors that have not improved with standard treatments. The drug is designed to target and attack cancer cells while limiting harm to healthy cells. The goal is to find the safest dose and…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New drug duo takes on advanced cancers
Disease control Recruiting nowThis study tests a new drug called ADG126 combined with an existing immunotherapy (pembrolizumab) in people with advanced or metastatic solid tumors. The goal is to find the safest and most effective dose and see if the combination can shrink tumors. About 186 adults with various…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Adagene Inc • Aim: Disease control
Last updated May 08, 2026 12:02 UTC